Majeed A - Search Results

1

A benefit-risk assessment of dabigatran in the prevention of venous thromboembolism in orthopaedic surgery.

Schulman S, Majeed A. Schulman S, et al. Among authors: majeed a. Drug Saf. 2011 Jun 1;34(6):449-63. doi: 10.2165/11587290-000000000-00000. Drug Saf. 2011. PMID: 21585219 Review.

2

The oral thrombin inhibitor dabigatran: strengths and weaknesses.

Schulman S, Majeed A. Schulman S, et al. Among authors: majeed a. Semin Thromb Hemost. 2012 Feb;38(1):7-15. doi: 10.1055/s-0031-1300946. Epub 2012 Feb 7. Semin Thromb Hemost. 2012. PMID: 22314598 Review.

3

Management and outcomes of major bleeding during treatment with dabigatran or warfarin.

Majeed A, Hwang HG, Connolly SJ, Eikelboom JW, Ezekowitz MD, Wallentin L, Brueckmann M, Fraessdorf M, Yusuf S, Schulman S. Majeed A, et al. Circulation. 2013 Nov 19;128(21):2325-32. doi: 10.1161/CIRCULATIONAHA.113.002332. Epub 2013 Sep 30. Circulation. 2013. PMID: 24081972 Free article. Clinical Trial.

4

Effectiveness and outcome of management strategies for dabigatran- or warfarin-related major bleeding events.

Majeed A, Hwang HG, Eikelboom JW, Connolly S, Wallentin L, Feuring M, Brueckmann M, Noack H, Yusuf S, Schulman S. Majeed A, et al. Thromb Res. 2016 Apr;140:81-88. doi: 10.1016/j.thromres.2016.02.005. Epub 2016 Feb 22. Thromb Res. 2016. PMID: 26908016 Clinical Trial.

5

Management of bleeding complications in patients with cancer on DOACs.

Schulman S, Shrum J, Majeed A. Schulman S, et al. Among authors: majeed a. Thromb Res. 2016 Apr;140 Suppl 1:S142-7. doi: 10.1016/S0049-3848(16)30113-X. Thromb Res. 2016. PMID: 27067968

6

Reversal of dabigatran-associated major bleeding with activated prothrombin concentrate: A prospective cohort study.

Schulman S, Ritchie B, Nahirniak S, Gross PL, Carrier M, Majeed A, Hwang HG, Zondag M; Study investigators. Schulman S, et al. Among authors: majeed a. Thromb Res. 2017 Apr;152:44-48. doi: 10.1016/j.thromres.2017.02.010. Epub 2017 Feb 16. Thromb Res. 2017. PMID: 28222322

7

Bleeding and antidotes in new oral anticoagulants.

Majeed A, Schulman S. Majeed A, et al. Best Pract Res Clin Haematol. 2013 Jun;26(2):191-202. doi: 10.1016/j.beha.2013.07.001. Epub 2013 Jul 21. Best Pract Res Clin Haematol. 2013. PMID: 23953907 Review.

8

Response to letter regarding article, "Management and outcomes of major bleeding during treatment with dabigatran or warfarin".

Majeed A, Hwang HG, Connolly SJ, Eikelboom JW, Ezekowitz MD, Wallentin L, Brueckmann M, Fraessdorf M, Yusuf S, Schulman S. Majeed A, et al. Circulation. 2014 Sep 2;130(10):e95. doi: 10.1161/CIRCULATIONAHA.114.010280. Circulation. 2014. PMID: 25210103 No abstract available.

9

Strategies and outcomes of periprocedural bridging therapy with low-molecular-weight heparin in patients with mechanical heart valves.

Schulman JM, Majeed A, Mattsson E, Schulman S, Holmström M, Ågren A. Schulman JM, et al. Among authors: majeed a. J Thromb Thrombolysis. 2015 Nov;40(4):430-6. doi: 10.1007/s11239-015-1216-4. J Thromb Thrombolysis. 2015. PMID: 25868460 Clinical Trial.

10

Bleeding events with dabigatran or warfarin in patients with venous thromboembolism.

Majeed A, Goldhaber SZ, Kakkar A, Kearon C, Eriksson H, Kreuzer J, Feuring M, Hantel S, Friedman J, Schellong S, Schulman S. Majeed A, et al. Thromb Haemost. 2016 Jan;115(2):291-8. doi: 10.1160/TH15-04-0319. Epub 2015 Sep 24. Thromb Haemost. 2016. PMID: 26403199 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,617 results

Search Page

Filters